Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations

Publisher： Karger

E-ISSN： 1421-9913|50|1|10-15

ISSN： 0014-3022

Source： European Neurology, Vol.50, Iss.1, 2003-06, pp. : 10-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

By Nagashima Takao   Minota Seiji  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 819-820

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Dermatomyositis and Polymyositis with Anti-Tumor Necrosis Factor-α: Long-Term Follow-Up

By  

European Neurology, Vol. 52, Iss. 1, 2004-07 ,pp. : 61-63

Karger

Access to resources Recommend Favorite

Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

By  

Case Reports in Gastroenterology, Vol. 8, Iss. 1, 2014-01 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor Blocking Agents in the Treatment of Systemic Vasculitis

By  

Current Immunology Reviews, Vol. 7, Iss. 4, 2011-11 ,pp. : 423-428

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-p53 antibodies in patients with dermatomyositis/polymyositis

By Mimura Yoshihiro   Yazawa Norihito   Tamaki Zenshirou   Ashida Ryuichi   Jinnin Masatoshi   Asano Yoshihide   Tada Yayoi   Kubo Masahide   Ihn Hironobu   Tamaki Kunihiko  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1328-1331

Springer Publishing Company

Access to resources Recommend Favorite